Evidence map›Paper›PMID 29741121›Full record

ReviewRNA biology2018

When SUMO met splicing.

Berta Pozzi, Pablo Mammi, Laureano Bragado, Luciana E Giono, Anabella Srebrow

Abstract readReview
In one paragraph

Review in RNA biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Spirocyclic β-lactone secondary metabolites modulate spliceosome function.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. SUMO conjugation to promoter-proximal sequence elements-associated proteins impacts on snRNA transcription.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. eLife · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. LncRNAActa pharmaceutica Sinica. B · 2022
    Article
  12. Exploring the multifunctionality of SR proteins.Biochemical Society transactions · 2022
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Berta Pozzia Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE, UBA- CONICET); Departamento de Fisiología, Biología Molecular y Celular, Facultad de Ciencias Exactas y Naturales , Universidad de Buenos Aires. Ciudad Universitaria , Buenos Aires , Argentina.
Pablo Mammia Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE, UBA- CONICET); Departamento de Fisiología, Biología Molecular y Celular, Facultad de Ciencias Exactas y Naturales , Universidad de Buenos Aires. Ciudad Universitaria , Buenos Aires , Argentina.
Laureano Bragadoa Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE, UBA- CONICET); Departamento de Fisiología, Biología Molecular y Celular, Facultad de Ciencias Exactas y Naturales , Universidad de Buenos Aires. Ciudad Universitaria , Buenos Aires , Argentina.
Luciana E Gionoa Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE, UBA- CONICET); Departamento de Fisiología, Biología Molecular y Celular, Facultad de Ciencias Exactas y Naturales , Universidad de Buenos Aires. Ciudad Universitaria , Buenos Aires , Argentina.
Anabella Srebrowa Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE, UBA- CONICET); Departamento de Fisiología, Biología Molecular y Celular, Facultad de Ciencias Exactas y Naturales , Universidad de Buenos Aires. Ciudad Universitaria , Buenos Aires , Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spliceosomal proteins have been revealed as SUMO conjugation targets. Moreover, we have reported that many of these are in a SUMO-conjugated form when bound to a pre-mRNA substrate during a splicing reaction. We demonstrated that SUMOylation of Prp3 (PRPF3), a component of the U4/U6 di-snRNP, is required for U4/U6•U5 tri-snRNP formation and/or recruitment to active spliceosomes. Expanding upon our previous results, we have shown that the splicing factor SRSF1 stimulates SUMO conjugation to several spliceosomal proteins. Given the relevance of the splicing process, as well as the complex and dynamic nature of its governing machinery, the spliceosome, the molecular mechanisms that modulate its function represent an attractive topic of research. We posit that SUMO conjugation could represent a way of modulating spliceosome assembly and thus, splicing efficiency. How cycles of SUMOylation/de-SUMOylation of spliceosomal proteins become integrated throughout the highly choreographed spliceosomal cycle awaits further investigation.

Indexed as

AnimalsHumansNuclear ProteinsRibonucleoprotein, U4-U6 Small NuclearRNA SplicingRNA Splicing FactorsSUMO-1 ProteinSumoylationNuclear ProteinsPRPF3 protein, humanRibonucleoprotein, U4-U6 Small NuclearRNA Splicing FactorsSUMO-1 Proteinpost-translational modificationsspliceosomeSplicingSR proteinsSRSF1SUMO conjugation

Identifiers

PMID29741121
PMCPMC6152442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.